REFERENCES
- Aiello L P, Gardner T W, King G L, Blankenship G, Cavallerano J D, Ferris F L, 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 1998; 21: 143–56, [PUBMED], [INFOTRIEVE], [CSA]
- Aiello L P, Wong J S. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int. 2000; 58: 113–119, [CROSSREF]
- Miller J W, Adamis A P, Aiello L P. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev. 1997; 13: 37–50, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lip P L, Belgore F, Blann A D, Hope-Ross M W, Gibson J M, Lip G Y. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: Relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci. 2000; 41: 2115–2119, [PUBMED], [INFOTRIEVE], [CSA]
- Aiello L P, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994; 331: 1519–1520, [see comments.] 1994;331:1480–1487[CROSSREF], [CSA]
- Ishida S, Shinoda K, Kawashima S, Oguchi Y, Okada Y, Ikeda E. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000; 41: 1649–1656, [PUBMED], [INFOTRIEVE], [CSA]
- Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13: 9–22, [PUBMED], [INFOTRIEVE], [CSA]
- Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 1997; 277: 48–50, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Joussen A M, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q, Moromizato Y, Bursell S E, Wiegand S J, Rudge J, et al. Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol. 2002; 160: 1683–1693, [PUBMED], [INFOTRIEVE]
- Drevs J, Hofmann I, Hugenschmidt H, Wittig C, Madjar H, Muller M, Wood J, Martiny-Baron G, Unger C, Marme D. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res. 2000; 60: 4819–4824, [PUBMED], [INFOTRIEVE]
- Cristofanilli M, Charnsangavej C, Hortobagyi G N. Angiogenesis modulation in cancer research: Novel clinical approaches. Nat Rev Drug Discov. 2002; 1: 415–426, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Aiello L P, Bursell S E, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla T A, Ways K, Jirousek M, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes. 1997; 46: 1473–1480, [PUBMED], [INFOTRIEVE]
- Smith L E, Wesolowski E, McLellan A, Kostyk S K, D'Amato R, Sullivan R, D'Amore P A. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994; 35: 101–111, [PUBMED], [INFOTRIEVE], [CSA]
- Connolly S E, Hores T A, Smith L E, D'Amore P A. Characterization of vascular development in the mouse retina. Microvasc Res. 1988; 36: 275–290, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Higgins R D, Yu K, Sanders R J, Nandgaonkar B N, Rotschild T, Rifkin D B. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res. 1999; 18: 20–27, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yossuck P, Yan Y, Tadesse M, Higgins R D. Dexamethasone and critical effect of timing on retinopathy. Invest Ophthalmol Vis Sci. 2000; 41: 3095–3099, [PUBMED], [INFOTRIEVE], [CSA]
- Korff T, Kimmina S, Martiny-Baron G, Augustin H G. Blood vessel maturation in a 3-dimensional spheroidal coculture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J. 2001; 15: 447–457, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Maisonpierre P C, Suri C, Jones P F, Bartunkova S, Wiegand S J, Radziejewski C, Compton D, McClain J, Aldrich T H, Papadopoulos N, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997; 277: 55–60, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hackett S F, Ozaki H, Strauss R W, Wahlin K, Suri C, Maisonpierre P, Yancopoulos G, Campochiaro P A. Angiopoietin 2 expression in the retina: Upregulation during physiologic and pathologic neovascularization. J Cell Physiol. 2000; 184: 275–284, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fiedler U, Krissl T, Koidl S, Weiss C, Koblizek T, Deutsch U, Martiny-Baron G, Marme D, Augustin H G. Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the EGF-like repeats. J Biol Chem. 2003; 278: 1721–1727, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G, Marme D, Martiny-Baron G. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J Biol Chem. 1997; 272: 10382–10388, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Aiello L P, Pierce E A, Foley E D, Takagi H, Chen H, Riddle L, Ferrara N, King G L, Smith L E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A. 1995; 92: 10457–10461, [PUBMED], [INFOTRIEVE], [CSA]
- Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard A L, Liu J L, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A. 2001; 98: 5804–5808, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Seo M S, Kwak N, Ozaki H, Yamada H, Okamoto N, Yamada E, Fabbro D, Hofmann F, Wood J M, Campochiaro P A. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol. 1999; 154: 1743–1753, [PUBMED], [INFOTRIEVE]
- McLeod D S, Taomoto M, Cao J, Zhu Z, Witte L, Lutty G A. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2002; 43: 474–482, [PUBMED], [INFOTRIEVE], [CSA]
- Robinson G S, Pierce E A, Rook S L, Foley E, Webb R, Smith L E. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A. 1996; 93: 4851–4856, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]